INmune Bio, Inc. (INMB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Graphite Bio, Inc.

TriSalus Life Sciences, Inc.

Seer, Inc. (California)

Heron Therapeutics, Inc.

Trevi Therapeutics, Inc.

Vor Biopharma, Inc.

Design Therapeutics, Inc.

Altimmune, Inc.

INmune Bio, Inc.

BioVie, Inc.

Vaxxinity, Inc.

Why is INmune Bio, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is INmune Bio, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

INmune Bio, Inc.

-79.58%

-0.84

100.17%

S&P 500

20.78%

1.67

13.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.98%

EBIT Growth (5y)

-201.39%

EBIT to Interest (avg)

-25.68

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.65

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

33.38%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.17

EV to EBIT

-0.07

EV to EBITDA

-0.07

EV to Capital Employed

-1.32

EV to Sales

2.50

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-133.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET PROFIT(HY)

Higher at USD -10.67 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-3What is not working for the Company

ROCE(HY)

Lowest at -168.78%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

Here's what is working for INmune Bio, Inc.

Net Profit

Higher at USD -10.67 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for INmune Bio, Inc.

Debtors Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio